Pictet Asset Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43M | Buy |
411,850
+78,645
| +24% | +$8.21M | 0.04% | 344 |
|
|
2025
Q1 | $38.9M | Buy |
333,205
+328,527
| +7,023% | +$38.3M | 0.04% | 355 |
|
|
2024
Q4 | $396K | Buy |
4,678
+761
| +19% | +$64.4K | ﹤0.01% | 1490 |
|
|
2024
Q3 | $352K | Sell |
3,917
-375
| -9% | -$33.7K | ﹤0.01% | 1514 |
|
|
2024
Q2 | $346K | Sell |
4,292
-348,074
| -99% | -$28M | ﹤0.01% | 1450 |
|
|
2024
Q1 | $28.1M | Sell |
352,366
-346,566
| -50% | -$27.6M | 0.03% | 413 |
|
|
2023
Q4 | $55.6M | Buy |
698,932
+52,503
| +8% | +$4.18M | 0.06% | 285 |
|
|
2023
Q3 | $45.2M | Buy |
+646,429
| New | +$45.2M | 0.06% | 305 |
|